PeerView

Dr. Mark Reding invites you to join him and Dr. Guy Young for a live symposium on advancing gene therapy in hemophilia B—don’t miss these expert insights on patient selection, care coordination, and real-world application 🧬 Join us this Saturday in Portland or virtually on March 30. Register now: bit.ly/Portland26-T #THSNA2026 #hemophilia #MedEd

How can bispecific antibodies improve ALL care? Learn through interactive questions and gain practical insights on managing patients with R/R #B-ALL: bit.ly/3LmdruE #MedEd #PeerView

How can quantitative analysis of #amyloidPET support early Alzheimer’s diagnosis and treatment monitoring? Explore real-world cases and expert insights in this Case Conference. #AlzheimersDisease bit.ly/3KMygit

Join me and Dr. Alexander for lunch during #HRS2026 on 4/23 to learn how to spot early transthyretin cardiac #amyloidosis and manage AF: bit.ly/4sWlvCE @PeerView #EPeeps #cardiology

Remember to join us next weekend on 3/28 at 6:00 AM PDT, for our #RSV in-person & virtual symposium: bit.ly/RSVPharmLA26-T #InfectiousDisease #forpharmacy #APhA2026

🧬 Gene therapy is redefining what disease control could look like—but key questions remain: Who? When? How? 🤔 Get real-world insights + expert guidance. Join @PeerView with @GuyYoungMD & Mark T. Reding, MD at #THSNA2026 👉 Sat 3/21 at 6:45 AM PDT 🔗 bit.ly/Portland26-T

Adapt to Advance in #ALL/LBL: Stay current on evolving standards of care in pediatric and AYA ALL/LBL management with Luke Maese, DO, and Rachel Rau, MD, at #ASPHO2026 on 4/30 at 7 AM CDT 🔗 bit.ly/ALLPed26-T

Join Kevin M. Alexander, MD, FACC, FHFSA (@KMAlexanderMD), & Eoin Donnellan, MD, on 4/23 at 11:00 AM CDT during #HRS2026 for an #ATTR #MedEd event ➡️ bit.ly/26ATTR-CA-T #EPeeps #cardiology #amyloidosis #MedEd

Remember to join us Wednesday, March 25, 11:30 AM CDT, for our extensive-stage #SCLC live in-person and virtual symposium: bit.ly/SCLCNOLA26-T #HOPA2026

#CRSwNP uncontrolled? Think type 2 inflammation 🔬 Biologics are changing the game—target the source 🎯 Join @PeerView this Saturday, 3/21 w/ Amber Luong, MD, PhD, Christopher D. Codispoti, MD, PhD & Carly Luethy, PA-C 🧠 Learn. Apply. Personalize. 🔗 bit.ly/2026CRSwNP-T

Remember to join us Saturday, March 21, at 12:00 PM CDT at ENT for the PA-C, for our #CRSwNP live in-person & virtual symposium 🔗 bit.ly/2026CRSwNP-T

"Smoothing the Way in #EoE: Targeted, Team-Based Strategies for Pediatric and Adult Care." Answer questions and test your knowledge in this #MedEd activity: bit.ly/47aAukE

Watch Shambavi Richard, MD & Joshua Richter, MD, FACP (@JoshuaRichterMD) discuss personalized sequencing with BCMA and non-BCMA immunotherapies in relapsed/refractory #MultipleMyeloma from #Tandem26. To participate: bit.ly/MM-26-T x.com/i/broadcasts/1…

Remember to join us Saturday, March 21, at 6:45 AM PDT, for our #hemophilia live in-person symposium ➡️ bit.ly/Portland26-T #THSNA2026

Uncontrolled #T2D? Many need insulin—don’t wait! 💉 🎰 Basal Insulin Casino at #AACE2026 🧠 Personalize care & overcome barriers Join @PeerView with @athenatsimikas, Harpreet Bajaj, MD & @cwysham on 04/22. Bet on basal #insulin—you can’t lose! 🔗 bit.ly/T2DVegas26-T

ReiNForcing Care Pathways in NF1-PN: Improve patient outcomes with MEK inhibition and coordinated care. Join the #Neurofibromatosis experts, Drs. Armstrong & Hirbe, in person or virtually during #ASPHO2026 on 4/29 at 11:15 AM CDT. Produced with @nfnetwork 🔗 bit.ly/NF26-T #HemeOnc

Drs. Roxana Mehran and Jeffrey Weitz discuss emerging FXI(a)-targeted anticoagulants and their potential to advance stroke and thrombosis prevention in #SecondaryStrokePrevention and #AtrialFibrillation ➡️ bit.ly/48qmOCZ #cardiology

Coordinating Transformative Care With #CART Therapy in Non-Hodgkin #Lymphoma with @SagheerTiba and Amanda Yepes, PharmD, BCOP #HemOnc #MedEd 📅 4/1 at 7 PM EST after #HOPA2026 🔗 bit.ly/CARTVirtual26-T

Join Christie M. Ballantyne, MD, FACP, FACC (@CBallantyneMD), Ann Marie Navar, MD, PhD, FAHA, FACC, FASPC (@AnnMarieNavar), and Marc S. Sabatine, MD, MPH, on 3/30 at 6:00 AM CDT during #ACC26 for a #Hypercholesterolemia #MedEd event ➡️ bit.ly/Lipids26-T Produced with @MendedHearts #Cardiology #PCSK9

Biologic therapy is a game changer in the treatment of patients with #COPD, particularly those with type 2 inflammation, but how can clinicians determine which patients are likely to benefit from a particular therapy? Find out in “Selecting the Right Biologic for the Right Person With COPD” on Thursday, 3/26, at 7 PM EDT—session 3 of a 4-part virtual live COPD ECHO® Program series from PeerView and @BU_CME: bit.ly/T2inCOPD-ECHO-T @ProjectECHO #AllTeachAllLearn